©istock.com/Andrea Obzerova
Interdisziplinäre KompetenzMolekulare Diagnostik
Know how bei der Analyse von Erbmaterial.
Zum Wohle von Patienten.

ErkrankungEpilepsien, metabolische; Differentialdiagnose

Zusammenfassung

Kurzinformation

Umfassendes differentialdiagnostisches panel für Epilepsien, metabolische mit 8 bzw. 58 kuratierten Genen gemäß klinischer Verdachtsdiagnose

ID
EP0374
Anzahl Gene
57 Akkreditierte Untersuchung
Untersuchte Sequenzlänge
14,4 kb (Core-/Basis-Gene)
81,4 kb (Erweitertes Panel)
Analyse-Dauer
auf Anfrage
Material
  • EDTA-Blut (3-5 ml)
Diagnostische Hinweise

NGS +

[[Sanger]]

 

Genpanel

Ausgewählte Gene

NameExon-Länge (bp)OMIM-GErbgang
ALDH7A11620AR
CLN31317AR
FOLR1774AR
GAMT711AR
GLDC3063AR
POLG3720AD und/oder AR
SLC2A11479AD und/oder AR
TPP11692AR
ABAT1503AR
AGK1269AR
ALDH5A11608AR
AMT1212AR
BCKDK1098AR
BOLA3324AR
CLN51077AR
CLN6936AR
CLN8861AR
COQ8A1944AR
CTSD1239AR
CTSF1455AR
DGUOK834AR
DHFR564AR
DNAJC5597AD
FBXL41866AR
FH1533AD und/oder AR und/oder SMu und/oder Sus
GALC2058AR
GATM1272AR
GCSH522AR
GLRX5474AR
GPHN2310AR
GRN1782AD und/oder AR
HCFC16108XLR
IBA571071AR
KCTD7870AR
L2HGDH1392AR
LIAS990AR
MFSD81557AR
MOCS11158AR
MOCS2567AR
MPV17531AR
NFU1765AR
OPA12883AD und/oder AR und/oder Mult
PNPO786AR
PPT1921AR
RRM2B1272AD und/oder AR
SLC25A4897AD und/oder AR
SLC6A92121AR
SLC8A12907AD
SUCLA21392AR
SUCLG11041AR
SUOX1638AR
TANGO21252AR
TBC1D241680AD und/oder AR
TFAM645AR
TK2705AR
TWNK2055AD und/oder AR
TYMP1449AR

Infos zur Erkrankung

Klinischer Kommentar

Neuro-metabolic epilepsies are inherited disorders with predominantly epileptic manifestations, or the epilepsy is part of a complex neurologic phenotype. Several of these disorders are treatable, but there are no specific clinical or electrographic features suggestive of metabolic epilepsies. Metabolic disorders can cause seizures in three different ways: Deficiency of substrates essential for neuro-cellular metabolism or membrane function, intracellular accumulation of neurotoxic substances, and alteration of intracellular osmolality in the brain. Thus, about half of the approximately 400 inborn errors of metabolism, i.e., manifold mutations in nearly 900 genes, may be associated with epilepsies. A search of the OMIM, PubMed and MEDLINE databases reveals that the majority of inborn errors of metabolism in epilepsy are transmitted in autosomal recessive manner (87%), whereas 6% are inherited in mitochondrial, 4% in X-linked and 3% in autosomal dominant manner. According to different study results, the DNA diagnostic yield can vary between 25-65% and more, so that nevertheless inconspicuous genetic findings do not mean a secure exclusion of the clinical suspected diagnoses.

References: https://www.ncbi.nlm.nih.gov/books/NBK1195/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369901/

Leitlinie: "Zwar haben die neuesten molekulargenetischen Befunde beigetragen, die Ursachen dieser häufigen idiopathischen Epilepsien etwas besser zu verstehen, doch ist eine routinemäßige genetische Diagnostik derzeit noch nicht sinnvoll.." GRIN2A, KCNT1, KCNQ2, KCNQ3, SCN1A Gene allerdings explizit erwähnt.

 

Synonyme
  • Allelic: Anemia, sideroblastic, 3, pyridoxine-refractory (GLRX5)
  • Allelic: Aphasia, primary progressive (GRN)
  • Allelic: Behr syndrome (OPA1)
  • Allelic: Charcot-Marie-Tooth disease, axonal, type 2EE (MPV17)
  • Allelic: Deafness, AD 65 (TBC1D24)
  • Allelic: Deafness, AR 86 (TBC1D24)
  • Allelic: Dystonia 9 (SLC2A1)
  • Allelic: Fanconi renotubular syndrome 1 (GATM)
  • Allelic: Frontotemporal lobar degeneration with ubiquitin-positive inclusions (GRN)
  • Allelic: Glaucoma, normal tension, susceptibility to (OPA1)
  • Allelic: Leiomyomatosis + renal cell cancer (FH)
  • Allelic: Macular dystrophy with central cone involvement (MFSD8)
  • Allelic: Mitochondrial DNA depletion syndrome 2, myopathic type (TK2)
  • Allelic: Optic atrophy 1 (OPA1)
  • Allelic: Optic atrophy plus syndrome (OPA1)
  • Allelic: Perrault syndrome 5 (TWNK)
  • Allelic: Portal hypertension, noncirrhotic, 1 (DGUOK)
  • Allelic: Progressive external ophthalmoplegia with mitochondrial DNA deletions, AR 4 (DGUOK)
  • Allelic: Progressive external ophthalmoplegia, AD 1 (POLG)
  • Allelic: Progressive external ophthalmoplegia, AR 1 (POLG)
  • Allelic: Spastic paraplegia 74, AR (IBA57)
  • Branched-chain ketoacid dehydrogenase kinase deficiency (BCKDK)
  • Cerebral creatine deficiency syndrome 2 (GAMT)
  • Cerebral creatine deficiency syndrome 3 (GATM)
  • Ceroid lipofuscinosis, neuronal, 1 (PPT1)
  • Ceroid lipofuscinosis, neuronal, 10 (CTSD)
  • Ceroid lipofuscinosis, neuronal, 11 (GRN)
  • Ceroid lipofuscinosis, neuronal, 13, Kufs type, AD (CTSF)
  • Ceroid lipofuscinosis, neuronal, 2 (TPP1)
  • Ceroid lipofuscinosis, neuronal, 3 (CLN3)
  • Ceroid lipofuscinosis, neuronal, 4, Kufs type (DNAJC5)
  • Ceroid lipofuscinosis, neuronal, 5 (CLN5)
  • Ceroid lipofuscinosis, neuronal, 6A (CLN6)
  • Ceroid lipofuscinosis, neuronal, 6B, Kufs type (CLN6)
  • Ceroid lipofuscinosis, neuronal, 7 (MFSD8)
  • Ceroid lipofuscinosis, neuronal, 8 (CLN8)
  • Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant (CLN8)
  • Coenzyme Q10 deficiency, primary, 4 (COQ8A)
  • Constitutional megaloblastic anemia with severe neurologic disease (DHFR)
  • DOORS [Deafness, Onychodystrophy, Osteodystrophy, mental Retard.] syndrome (TBC1D24)
  • Developmental + epileptic encephalopathy 16 (TBC1D24)
  • Epilepsy, idiopathic generalized, susceptibility to, 12 (SLC2A1)
  • Epilepsy, progressive myoclonic 3, with/-out intracellular inclusions (KCTD7)
  • Epilepsy, pyridoxine-dependent (ALDH7A1)
  • Epilepsy, rolandic, with proxysmal exercise-induce dystonia + writer's cramp (TBC1D24)
  • Epilepsy-associated gene [Lit.] (SLC8A9)
  • Fumarase deficiency (FH)
  • GABA-transaminase deficiency (ABAT)
  • GLUT1 deficiency syndrome 1, infantile onset, severe (SLC2A1)
  • GLUT1 deficiency syndrome 2, childhood onset (SLC2A1)
  • Glycine encephalopathy (GCSH)
  • Glycine encephalopathy (GLDC)
  • Glycine encephalopathy with normal serum glycine (SLC6A9)
  • Hyperglycinemia, lactic acidosis + seizures (LIAS)
  • Krabbe disease (GALC)
  • L-2-hydroxyglutaric aciduria (L2HGDH)
  • Megaloblastic anemia with severe neurologic disease (DHFR)
  • Metabolic encephalomyopathic crises, recurrent, rhabdomyol., cardiac arrhythmias, neurodeg. (TANGO2)
  • Metabolic encephalomyopathic crises, recurrent, rhabdomyolysis, cardiac arrhyth., neurodeg. (TANGO2)
  • Methylmalonic acidemia + homocysteinemia, cblX type (HCFC1)
  • Mitochondrial DNA depletion syndrome 1, MNGIE type (TYMP)
  • Mitochondrial DNA depletion syndrome 12A, cardiomyopathic type, AD (SLC25A4
  • Mitochondrial DNA depletion syndrome 12B, cardiomyopathic type, AR (SLC25A4)
  • Mitochondrial DNA depletion syndrome 13, encephalomyopathic type (FBXL4)
  • Mitochondrial DNA depletion syndrome 14, encephalocardiomyopathic type (OPA1)
  • Mitochondrial DNA depletion syndrome 15, hepatocerebral type (TFAM)
  • Mitochondrial DNA depletion syndrome 3, hepatocerebral type (DGUOK)
  • Mitochondrial DNA depletion syndrome 4A, Alpers type (POLG)
  • Mitochondrial DNA depletion syndrome 4B, MNGIE type (POLG)
  • Mitochondrial DNA depletion syndrome 5, encephalomyopathic +/- methylmalonic aciduria (SULC2)
  • Mitochondrial DNA depletion syndrome 6, hepatocerebral type (MPV17)
  • Mitochondrial DNA depletion syndrome 7, hepatocerebral type (TWNK)
  • Mitochondrial DNA depletion syndrome 8A, encephalomyopathic type with renal tubulopathy (RRM2B)
  • Mitochondrial DNA depletion syndrome 8B, MNGIE type (RRM2B)
  • Mitochondrial DNA depletion syndrome 9, encephalomyopathic type with methylmalonic aciduria (SUCLG1)
  • Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE] (POLG)
  • Molybdenum cofactor deficiency A (MOCS1)
  • Molybdenum cofactor deficiency B (MOCS2)
  • Molybdenum cofactor deficiency C (GPHN)
  • Multiple mitochondrial dysfunctions syndrome 1 (NFU1)
  • Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia (BOLA3)
  • Multiple mitochondrial dysfunctions syndrome 3 (IBA57)
  • Myoclonic epilepsy, infantile, familial (TBC1D24)
  • Neurodegeneration due to cerebral folate transport deficiency (FOLR1)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AD 2 (SLC25A4)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AD 3 (TWNK)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AD 5 (RRM2B)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AR 2 (RNASEH1)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AR 3 (TK2)
  • Pyridoxamine 5'-phosphate oxidase deficiency (PNPO)
  • Sengers syndrome (AGK)
  • Spasticity, childhood-onset, with hyperglycinemia (GLRX5)
  • Spinocerebellar ataxia, autosomal recessive 7 (TPP1)
  • Stomatin-deficient cryohydrocytosis with neurologic defects (SLC2A1)
  • Succinic semialdehyde dehydrogenase deficiency (ALDH5A1)
  • Sulfite oxidase deficiency (SUOX)
Erbgänge, Vererbungsmuster etc.
  • AD
  • AD und/oder AR
  • AD und/oder AR und/oder Mult
  • AD und/oder AR und/oder SMu und/oder Sus
  • AR
  • XLR
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code
G40.-

Bioinformatik und klinische Interpretation

Kein Text hinterlegt